Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
SILO Stock — Silo Pharma Inc
Silo Pharma Inc (SILO)
Updated October 16, 2026.
SILO is a Stock. Total return is -49.8% over the past 12.4 years, 444.8 points behind SPY at 395.0%.
Silo Pharma is a developmental stage biopharmaceutical company focused on creating therapeutics for underserved conditions including post-traumatic stress disorder, anxiety disorders, fibromyalgia, and central nervous system diseases, with programs ranging from clinical-stage candidates like an intranasal PTSD treatment to preclinical compounds for Alzheimer's disease and multiple sclerosis. The company does not currently distribute to shareholders. Silo Pharma appeals to investors seeking exposure to early-stage biotech development, particularly those interested in psychedelic-assisted and novel treatment approaches, though investors should be aware that developmental stage companies carry substantial risk.
SILO performance versus SPY
Price and return data through 2026-10-16.
Total return is -49.8% over the past 12.4 years, 444.8 points behind SPY at 395.0%. Over the past year its total return — price change plus distributions reinvested — is -86.9%. Its deepest 1-year drawdown was 88.2%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -32.9% | — |
| 3M | -75.3% | — |
| 6M | -84.5% | — |
| YTD | -76.9% | — |
| 1Y | -86.9% | — |
| 2Y CAGR | — | -74.10% |
| 3Y CAGR | — | -61.70% |
| 5Y CAGR | — | -62.30% |
| Since inception (12.4 years) | -49.8% | -5.40% |
SILO key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 05/13/2014
- Distribution frequency
- None
- Last close
- $1.18 (as of 2026-10-16)
- Market cap
- $2,422,835
- Average volume
- 9765.0
- Beta
- 0.91
- Payout ratio
- 0.0%
- EPS
- $-4.26
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
SILO risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 88.2%.
Who may consider SILO — and who may not
It is a weaker fit for investors who need monthly cash flow (SILO does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on SILO
Frequently asked questions
Does SILO pay monthly?
No. SILO does not currently distribute.
When does SILO pay a dividend?
SILO does not currently distribute.
How has SILO performed?
Total return is -49.8% over the past 12.4 years, 444.8 points behind SPY at 395.0%. Over the past year its total return — price change plus distributions reinvested — is -86.9%. Its deepest 1-year drawdown was 88.2%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.